Page last updated: 2024-11-07

2,8-dihydroxyquinoline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

2,8-Dihydroxyquinoline is a heterocyclic organic compound with the molecular formula C9H7NO2. It is a white solid that is soluble in water and organic solvents. It is a versatile compound with a variety of applications. It has been investigated for its potential as a chelating agent, an antioxidant, and a drug. It is also known to have antimicrobial and antifungal properties. Synthesis of 2,8-dihydroxyquinoline can be achieved through a multi-step process involving the reaction of 2-aminophenol with a suitable carbonyl compound, such as benzaldehyde, followed by cyclization. The compound is known to exhibit chelating properties, forming complexes with metal ions, which has led to its exploration for applications in analytical chemistry and environmental remediation. Its antioxidant properties arise from its ability to scavenge free radicals, making it potentially useful in preventing oxidative stress. Studies have shown that 2,8-dihydroxyquinoline has inhibitory effects on microbial growth, including bacteria and fungi, suggesting its potential as an antimicrobial agent. The compound's diverse range of properties and its potential applications in various fields have made it a subject of ongoing research.'

Cross-References

ID SourceID
PubMed CID97250
CHEMBL ID5083704
CHEBI ID17715
CHEBI ID48988
SCHEMBL ID470073
MeSH IDM0141895

Synonyms (58)

Synonym
BIDD:GT0382
AC-7834
AKOS003392316
CHEBI:17715
quinoline-2,8-diol
8-hydroxy-1h-quinolin-2-one
8-hydroxyquinolone
OPREA1_105139
8-hydroxycarbostyril
nsc-108383
2(1h)-quinolinone, 8-hydroxy-
8-hydroxycarbostyryl
2,8-dihydroxyquinoline ,
15450-76-7
nsc108383
2,8-quinolinediol
carbostyril, 8-hydroxy-
8-hydroxy-2-quinolone
8-hydroxyquinolin-2(1h)-one
CHEBI:48988
quinolin-2,8-diol
C06342 ,
OPREA1_245682
2,8-quinolinediol, >=99.0% (hplc)
2,8-dihydroxyquinoline;8-hydroxyquinolin-2(1h)-one
8-hydroxy-2-quinolinone
D3819
EN300-55308
AKOS006220464
466pko4ubm ,
nsc 108383
unii-466pko4ubm
FT-0601383
8-hydroxyquinolinol
8-hydroxy quinolone
8-hydroxy-(1h)-quinolin-2-one
AB01006045-01
FS-2243
SCHEMBL470073
SY014374
mfcd00216696
8-hydroxy-2(1h)-quinolinone #
J-650052
W-205767
DTXSID70165650
8-hydroxy-2(1h)-quinolinone
SR-01000388302-1
sr-01000388302
CS-D1708
8-hydroxy-1,2-dihydroquinolin-2-one
Z839575736
8-hydroxyquinolin-2-one
8-hydroxy-2-oxo-1,2-dihydroquinoline
2,8-dihydroxyquinoline; 8-hydroxy-1h-quinolin-2-one; 8-hydroxy-2-oxo-1,2-dihydroquinoline; 8-hydroxycarbostyril; 8-hydroxyquinolin-2-one
AMY24171
SB40799
CHEMBL5083704
PD056110
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
dihydroxyquinolineAny hydroxyquinoline in which the number of hydroxy substituents is specified as two.
monohydroxyquinolineA hydroxyquinoline carrying a single hydroxy substituent.
quinolone
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1824260Inhibition of recombinant NDM-1 (unknown origin) using fluorocillin as substrate at 30 uM incubated for 30 mins by fluorescence based assay2022European journal of medicinal chemistry, Jan-15, Volume: 228Nitroxoline and its derivatives are potent inhibitors of metallo-β-lactamases.
AID1824262Inhibition of recombinant NDM-1 (unknown origin) using fluorocillin as substrate at 3 uM incubated for 30 mins by fluorescence based assay2022European journal of medicinal chemistry, Jan-15, Volume: 228Nitroxoline and its derivatives are potent inhibitors of metallo-β-lactamases.
AID1824261Inhibition of recombinant NDM-1 (unknown origin) using fluorocillin as substrate at 10 uM incubated for 30 mins by fluorescence based assay2022European journal of medicinal chemistry, Jan-15, Volume: 228Nitroxoline and its derivatives are potent inhibitors of metallo-β-lactamases.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's2 (33.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.89

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.89 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.89)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]